Name: Latest research reports of Laurus Labs Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

1228.3000 21.80 (1.81%)

NSE May 08, 2026 15:31 PM

New 52W High today

Volume: 2.0M

Laurus Labs Ltd.

25 Oct 2024

1228.30

1.81%

Laurus Labs (SELL): Another weak quarter

Sell: Laurus Labs Ltd.

BOB Capital Markets Ltd.

Earnings miss for 2Q on our and street estimates on all fronts. Revenue/PAT came short of consensus estimates by -5%/39%

Deven Choksey upgraded Laurus Labs Ltd. to Accumulate with a price target of 1281.0 on 07 May, 2026.